Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Siegfried to build new production plant in China
The new plant, supported by NETDA, a Chinese development organization, will include production of active pharmaceutical ingredients and intermediates in its initial phase. The company is expecting to
The new plant, supported by NETDA, a Chinese development organization, will include production of active pharmaceutical ingredients and intermediates in its initial phase. The company is expecting to
The acquisition will enable Brenntag to expand its existing specialty product portfolio in the region for industries like pharmaceuticals, personal care, food & beverage as well as coatings.
The company also revealed aldoxorubucin as the new generic name for INNO-206, the conjugate which comprises the protein-binding linker technology, a chemotherapeutic drug doxorubicin. CytRx president and CEO
The letter was issued in late May based on inspections conducted in December and January, according to the Associated Press. The US Food and Drug Administration has issued
According to the revised agreement, NPS will earn a one-time $25m payment in July 2012 in exchange for its rights to receive royalties under the license agreement that
ERT is a technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives. ERT CEO Jeffrey Litwin
Upon the conclusion of the agreement, AnGes will earn upfront payments and milestone payments. AnGes expects to maximize the asset value of Collategene by conducting a prompt global
The company proposed the injection for the treatment of symptomatic Vitreomacular Adhesion (VMA) including macular hole. ThromboGenics CEO Patrik De Haes said that the FDA has granted ocriplasmin
Mylan gained final FDA approval for its abbreviated new drug application for Desloratadine Tablets, 5mg, and is shipping the product immediately. According to IMS Health, Desloratadine Tablets, 5mg,
The particulate matter, which has been recognized as a potential health hazard, was identified as active drug substance and not foreign material or contamination. Vein irritation and phlebitis,